# Provident Financial Holdings Inc: financial statements, quarterly

PROV · Nasdaq · CIK 1010470 · [Financials](/sectors/financials.md) · fiscal year ends Jun 30

Pages: [Overview](/companies/prov.md) · [Financials](/companies/prov/financials.md) · [Filings](/companies/prov/filings.md) · [Insiders](/companies/prov/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/prov/financials.md?period=annual).

## Income statement

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Selling, general and administrative | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $k | [4,203](/filings/0000939057-23-000329.md) | [4,891](/filings/0000939057-24-000046.md) | [5,248](/filings/0000939057-24-000106.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $k | [727](/filings/0000939057-24-000297.md) | [884](/filings/0000939057-25-000028.md) | [620](/filings/0000939057-25-000131.md) | [805 d](/filings/0000939057-25-000242.md) | [789](/filings/0001010470-25-000005.md) | [352](/filings/0001010470-26-000003.md) | [797](/filings/0001010470-26-000007.md) | [680 d](/filings/0001010470-26-000010.md) | [1,054](/filings/0001010470-25-000005.md) | [614](/filings/0001010470-26-000003.md) | [557](/filings/0001010470-26-000007.md) | [756 d](/filings/0001010470-26-000010.md) |
| Net income | $k | [1,762](/filings/0000939057-24-000297.md) | [2,141](/filings/0000939057-25-000028.md) | [1,495](/filings/0000939057-25-000131.md) | [1,953 d](/filings/0000939057-25-000242.md) | [1,900](/filings/0001010470-25-000005.md) | [872](/filings/0001010470-26-000003.md) | [1,857](/filings/0001010470-26-000007.md) | [1,626 d](/filings/0001010470-26-000010.md) | [1,681](/filings/0001010470-25-000005.md) | [1,436](/filings/0001010470-26-000003.md) | [1,354](/filings/0001010470-26-000007.md) | [2,184 d](/filings/0001010470-26-000010.md) |
| Diluted EPS | $ per share | [0.25](/filings/0000939057-24-000297.md) | [0.31](/filings/0000939057-25-000028.md) | [0.22](/filings/0000939057-25-000131.md) | not reported | [0.28](/filings/0001010470-25-000005.md) | [0.13](/filings/0001010470-26-000003.md) | [0.28](/filings/0001010470-26-000007.md) | not reported | [0.25](/filings/0001010470-25-000005.md) | [0.22](/filings/0001010470-26-000003.md) | [0.21](/filings/0001010470-26-000007.md) | not reported |
| Basic EPS | $ per share | [0.25](/filings/0000939057-24-000297.md) | [0.31](/filings/0000939057-25-000028.md) | [0.22](/filings/0000939057-25-000131.md) | not reported | [0.28](/filings/0001010470-25-000005.md) | [0.13](/filings/0001010470-26-000003.md) | [0.28](/filings/0001010470-26-000007.md) | not reported | [0.26](/filings/0001010470-25-000005.md) | [0.22](/filings/0001010470-26-000003.md) | [0.21](/filings/0001010470-26-000007.md) | not reported |

- Selling, general and administrative: not reported
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [58.0](/filings/0000939057-23-000329.md) | [46.9](/filings/0000939057-24-000046.md) | [51.7](/filings/0000939057-24-000106.md) | [51.4](/filings/0000939057-25-000242.md) | [48.2](/filings/0000939057-24-000297.md) | [45.5](/filings/0000939057-25-000028.md) | [50.9](/filings/0000939057-25-000131.md) | [53.1](/filings/0001010470-26-000010.md) | [49.4](/filings/0001010470-25-000005.md) | [54.4](/filings/0001010470-26-000003.md) | [57.1](/filings/0001010470-26-000007.md) | [49.2](/filings/0001010470-26-000010.md) |
| Total assets | $m | [1,313](/filings/0000939057-23-000329.md) | [1,301](/filings/0000939057-24-000046.md) | [1,290](/filings/0000939057-24-000106.md) | [1,272](/filings/0000939057-25-000242.md) | [1,257](/filings/0000939057-24-000297.md) | [1,255](/filings/0000939057-25-000028.md) | [1,260](/filings/0000939057-25-000131.md) | [1,246](/filings/0001010470-26-000010.md) | [1,231](/filings/0001010470-25-000005.md) | [1,228](/filings/0001010470-26-000003.md) | [1,218](/filings/0001010470-26-000007.md) | [1,208](/filings/0001010470-26-000010.md) |
| Total liabilities | $m | [1,184](/filings/0000939057-23-000329.md) | [1,171](/filings/0000939057-24-000046.md) | [1,161](/filings/0000939057-24-000106.md) | [1,142](/filings/0000939057-25-000242.md) | [1,128](/filings/0000939057-24-000297.md) | [1,126](/filings/0000939057-25-000028.md) | [1,131](/filings/0000939057-25-000131.md) | [1,117](/filings/0001010470-26-000010.md) | [1,102](/filings/0001010470-25-000005.md) | [1,100](/filings/0001010470-26-000003.md) | [1,091](/filings/0001010470-26-000007.md) | [1,082](/filings/0001010470-26-000010.md) |
| Shareholders' equity | $m | [129](/filings/0000939057-25-000028.md) | [130](/filings/0000939057-25-000131.md) | [130](/filings/0000939057-25-000131.md) | [130](/filings/0001010470-26-000010.md) | [130](/filings/0001010470-26-000003.md) | [129](/filings/0001010470-26-000007.md) | [129](/filings/0001010470-26-000007.md) | [129](/filings/0001010470-26-000010.md) | [128](/filings/0001010470-26-000003.md) | [127](/filings/0001010470-26-000007.md) | [127](/filings/0001010470-26-000007.md) | [126](/filings/0001010470-26-000010.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [3,364](/filings/0000939057-24-000297.md) | [94.0 d](/filings/0000939057-25-000028.md) | [2,983 d](/filings/0000939057-25-000131.md) | [(756) d](/filings/0000939057-25-000242.md) | [2,559](/filings/0001010470-25-000005.md) | [324 d](/filings/0001010470-26-000003.md) | [3,322 d](/filings/0001010470-26-000007.md) | [2,480 d](/filings/0001010470-26-000010.md) | [2,496](/filings/0001010470-25-000005.md) | [1,219 d](/filings/0001010470-26-000003.md) | [1,890 d](/filings/0001010470-26-000007.md) | [3,365 d](/filings/0001010470-26-000010.md) |
| Capital expenditure | $k | [564](/filings/0000939057-24-000297.md) | [536 d](/filings/0000939057-25-000028.md) | [395 d](/filings/0000939057-25-000131.md) | [94.0 d](/filings/0000939057-25-000242.md) | [171](/filings/0001010470-25-000005.md) | [17.0 d](/filings/0001010470-26-000003.md) | [29.0 d](/filings/0001010470-26-000007.md) | [313 d](/filings/0001010470-26-000010.md) | [44.0](/filings/0001010470-25-000005.md) | [187 d](/filings/0001010470-26-000003.md) | [145 d](/filings/0001010470-26-000007.md) | [56.0 d](/filings/0001010470-26-000010.md) |
| Dividends paid | $k | [981](/filings/0000939057-24-000297.md) | [976 d](/filings/0000939057-25-000028.md) | [968 d](/filings/0000939057-25-000131.md) | [962 d](/filings/0000939057-25-000242.md) | [961](/filings/0001010470-25-000005.md) | [946 d](/filings/0001010470-26-000003.md) | [935 d](/filings/0001010470-26-000007.md) | [924 d](/filings/0001010470-26-000010.md) | [921](/filings/0001010470-25-000005.md) | [906 d](/filings/0001010470-26-000003.md) | [891 d](/filings/0001010470-26-000007.md) | [874 d](/filings/0001010470-26-000010.md) |
| Share repurchases | $k | [495](/filings/0000939057-24-000297.md) | [762 d](/filings/0000939057-25-000028.md) | [707 d](/filings/0000939057-25-000131.md) | [637 d](/filings/0000939057-25-000242.md) | [1,464](/filings/0001010470-25-000005.md) | [1,030 d](/filings/0001010470-26-000003.md) | [801 d](/filings/0001010470-26-000007.md) | [1,153 d](/filings/0001010470-26-000010.md) | [1,059](/filings/0001010470-25-000005.md) | [1,536 d](/filings/0001010470-26-000003.md) | [1,497 d](/filings/0001010470-26-000007.md) | [1,891 d](/filings/0001010470-26-000010.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2022-09-30) | Q2 FY2023 (2022-12-31) | Q3 FY2023 (2023-03-31) | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [7,310](/filings/0000939057-23-000329.md) | [7,237](/filings/0000939057-24-000046.md) | [7,146](/filings/0000939057-24-000106.md) | [7,027](/filings/0000939057-24-000297.md) | [6,981](/filings/0000939057-25-000028.md) | [6,935](/filings/0000939057-25-000131.md) | [6,863](/filings/0001010470-25-000005.md) | [6,793](/filings/0001010470-26-000003.md) | [6,733](/filings/0001010470-26-000007.md) | [6,626](/filings/0001010470-25-000005.md) | [6,531](/filings/0001010470-26-000003.md) | [6,447](/filings/0001010470-26-000007.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 6,233,958 at 2026-08-31, from the cover of the [10-K filed 2026-09-02](/filings/0001010470-26-000010.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:30 ET. No prices; not investment advice.